Panel Discussion: Planning & Executing Smooth Transitions from EAP to Commercial Supply

• Anticipating patient needs and country-specific timelines to maintain uninterrupted access during program closure or handover
• Aligning internal teams, local stakeholders, and advocacy groups to address operational, regulatory, and financial challenges
• Learning from real-world multi-country cases to optimize transition planning and avoid common pitfalls

Speakers:

Sarah Moore

Director, Pre-Approval Access Strategy, Oncology

ImmunoGen

Cristian Argueta

Former Director, Market Access

AstraZeneca